Structural Formula (Image 1)
Ezetimibe
Product Images NDC 0591-3713
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 0591-3713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
10 mg (Image 2)
This is a medication called Ezetimibe, available in tablet form, with each tablet containing 10mg of the medication. The usual dosage is one tablet per day. It is manufactured in India by Watson Pharma Private Limited and distributed by Actavis Pharma, Inc. The medication should be stored in a controlled room temperature of 20°C to 25°C and protected from moisture. The lot number is 0591-3713-30 and it is available only on prescription. Additionally, the pharmacist is required to dispense the Patient Information leaflet to each patient.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
